![Jennifer Cochran](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Cochran
Directeur/Membre du Conseil chez
OMNIAB, INC.
Fortune : 455 774 $ au 30/06/2026
Profil
Jennifer Cochran is the founder of TwoStep Therapeutics, Inc., founded in 2024, with no titles listed.
Dr. Cochran is the founder of Red Tree Venture Capital, founded in 2020, with no titles listed.
Dr. Cochran is the founder of Switch Bioworks, Inc., founded in 2022, serving as Director.
Dr. Cochran was also the founder of xCella Biosciences, Inc...
Dr. Cochran was previously Director at Revel Pharmaceuticals, Inc., Director at Virsti Therapeutics, Inc., Independent Director at OmniAb Operations, Inc., Independent Director at OmniAb, Inc. since 2022, Director at Biograph 55, Inc., Director at Rondo Therapeutics, Inc., Director at Tachyon Therapeutics, Inc., Director at Kivu Bioscience, Inc., Director at Excellergy Therapeutics, and Professor at Stanford University since 2005.
Former positions include Independent Director at Ligand Pharmaceuticals, Inc., Director at Combangio, Inc., Director at Nodus Therapeutics, Inc., and Chief Scientist at Lagunita Biosciences LLC from 2015 to 2020.
Education includes a doctorate from Massachusetts Institute of Technology and an undergraduate degree from the University of Delaware.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OMNIAB, INC. 0,13 % | 17/06/2026 | 185 274 ( 0,13 % ) | 455 774 $ | 30/06/2026 |
Postes actifs de Jennifer Cochran
| Sociétés | Poste | Début |
|---|---|---|
| OMNIAB, INC. | Directeur/Membre du Conseil | 01/11/2022 |
Revel Pharmaceuticals, Inc.
 Revel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutic enzymes to degrade molecular damage that accumulates with aging | Directeur/Membre du Conseil | - |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2005 |
Rondo Therapeutics, Inc.
 Rondo Therapeutics, Inc. BiotechnologyHealth Technology Develops immune-cell engaging bispecific antibodies | Directeur/Membre du Conseil | - |
Biograph 55, Inc.
 Biograph 55, Inc. BiotechnologyHealth Technology Operates as biotechnology firm | Directeur/Membre du Conseil | - |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | Directeur/Membre du Conseil | - |
Switch Bioworks, Inc.
 Switch Bioworks, Inc. Chemicals: AgriculturalProcess Industries Manufactures synthetic nitrogen fertilizers | Fondateur | 01/01/2022 |
Anciens postes connus de Jennifer Cochran
| Sociétés | Poste | Fin |
|---|---|---|
Lagunita Biosciences LLC
 Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences invests in companies located in the United States. It focuses on companies operating in the fields of ophthalmology, protein engineering, drug discovery, surgical devices and mobile health services. It participates in early stage transactions. | Directeur Technique/Scientifique/R&D | 01/04/2020 |
| LIGAND PHARMACEUTICALS INCORPORATED | Directeur/Membre du Conseil | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Formation de Jennifer Cochran
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lagunita Biosciences LLC
Lagunita Biosciences LLC Investment ManagersFinance Lagunita Biosciences invests in companies located in the United States. It focuses on companies operating in the fields of ophthalmology, protein engineering, drug discovery, surgical devices and mobile health services. It participates in early stage transactions. | Finance |
xCella Biosciences, Inc.
 xCella Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes immuno-oncology antibody therapeutics | Health Technology |
Revel Pharmaceuticals, Inc.
Revel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutic enzymes to degrade molecular damage that accumulates with aging | Health Technology |
Red Tree Venture Capital
 Red Tree Venture Capital Investment ManagersFinance Red Tree Venture Capital seeks investment opportunities in companies located in the US. The firm targets companies operating in the fields of life science innovation sectors. It provides financing for early stage capital requirements. | Finance |
Combangio, Inc.
 Combangio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company which develops regenerative bio-therapeutics for severe ocular diseases | Commercial Services |
Biograph 55, Inc.
Biograph 55, Inc. BiotechnologyHealth Technology Operates as biotechnology firm | Health Technology |
Virsti Therapeutics, Inc. | |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | Health Technology |
Rondo Therapeutics, Inc.
Rondo Therapeutics, Inc. BiotechnologyHealth Technology Develops immune-cell engaging bispecific antibodies | Health Technology |
Switch Bioworks, Inc.
Switch Bioworks, Inc. Chemicals: AgriculturalProcess Industries Manufactures synthetic nitrogen fertilizers | Process Industries |
Nodus Therapeutics, Inc. | |
OmniAb, Inc.
 OmniAb, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
